Focused on identifying âsuper bugsâ that may unlie drug resistant infections, 3i Diagnostics, Inc. is organized around developing a new diagnostic platform capable of very rapidly isolating microbes, bacteria and fungi from a blood sample. Awarded "Breakthrough Device" designation by the FDA, the firm's product is called BiospectrixTM: a new type of diagnostic platform that removes all the components of a blood sample but isolates the bacteria that needs identification. Effectively removing all the noise and interference that the blood components of the sample cause when identifying the bacteria, the firm's system then scans the bacteria with a proprietary infrared scanner that characterizes the unique molecular structure of that organism enabling identiffication of the organism by looking up the scanning pattern in a databas
